Edwards Lifesciences (Mexico) Insiders

EW Stock  MXN 1,544  96.00  6.63%   
Edwards Lifesciences employs about 15.7 K people. The company is managed by 21 executives with a total tenure of roughly 163 years, averaging almost 7.0 years of service per executive, having 747.62 employees per reported executive. Break down of Edwards Lifesciences' management performance can provide insight into the company performance.
Michael Mussallem  Chairman
Chairman of the Board, Chief Executive Officer
Scott Ullem  President
Chief Financial Officer, Corporate Vice President
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Edwards Lifesciences Management Team Effectiveness

The company has return on total asset (ROA) of 0.1332 % which means that it generated a profit of $0.1332 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2614 %, meaning that it generated $0.2614 on every $100 dollars invested by stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.
100%

Edwards Lifesciences Workforce Comparison

Edwards Lifesciences is one of the top stocks in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 572,967. Edwards Lifesciences holds roughly 15,700 in number of employees claiming about 2.74% of all equities under Medical Devices industry.
JavaScript chart by amCharts 3.21.15OthersGFINBUROGOOGKOFUBLSAPNEW
The company has Profit Margin (PM) of 0.28 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33.

Edwards Lifesciences Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Edwards Lifesciences Price Series Summation is a cross summation of Edwards Lifesciences price series and its benchmark/peer.
JavaScript chart by amCharts 3.21.15Dec2025FebJan 13Jan 20Jan 27FebFeb 10Feb 171,4401,4601,4801.5K1,5201,540 20K40K60K80K 2.9K2,9503K3,050 1,4401,4601,4801.5K1,5201,540 Show all
JavaScript chart by amCharts 3.21.15Edwards Lifesciences Volume Edwards Lifesciences Closing Prices Abbott Laboratories Closing Prices - Benchmark Edwards Lifesciences Price Series Summation

Edwards Lifesciences Notable Stakeholders

An Edwards Lifesciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Edwards Lifesciences often face trade-offs trying to please all of them. Edwards Lifesciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Edwards Lifesciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael MussallemChairman of the Board, Chief Executive OfficerProfile
Scott UllemChief Financial Officer, Corporate Vice PresidentProfile
Martha MarshLead Independent DirectorProfile
Paul LaVioletteDirectorProfile
Larry WoodCorporate Vice President - Transcatheter Aortic Valve ReplacementProfile
Nicholas ValerianiIndependent DirectorProfile
Heisz StoneIndependent DirectorProfile
Mark WilterdingVP RelationsProfile
Catherine SzymanCorporate Vice President - Critical CareProfile
Daveen ChopraCorporate Vice President - Surgical Structural HeartProfile
Arnold PinkstonCorp CounselProfile
Huimin WangCorporate Vice President - Japan, Asia and PacificProfile
JeanLuc LemercierCorporate Vice President - EMEA (Europe, Middle East and Africa)Profile
Christine McCauleyCo HRProfile
Steven LorangerIndependent DirectorProfile
William LinkIndependent DirectorProfile
Kieran GallahueIndependent DirectorProfile
Ramona SequeiraDirectorProfile
Donald BoboCorporate Vice President - Strategy and Corporate DevelopmentProfile
Todd BrintonCo OfficerProfile
Dirksen LehmanCo AffairsProfile

About Edwards Lifesciences Management Performance

The success or failure of an entity such as Edwards Lifesciences often depends on how effective the management is. Edwards Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Edwards management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Edwards management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. EDWARDS LIFESCIENCES operates under Medical Devices classification in Mexico and is traded on Mexico Stock Exchange. It employs 14900 people.
Please note, the imprecision that can be found in Edwards Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Edwards Lifesciences. Check Edwards Lifesciences' Beneish M Score to see the likelihood of Edwards Lifesciences' management manipulating its earnings.

Edwards Lifesciences Workforce Analysis

Traditionally, organizations such as Edwards Lifesciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Edwards Lifesciences within its industry.

Edwards Lifesciences Manpower Efficiency

Return on Edwards Lifesciences Manpower

Revenue Per Employee342.8K
Revenue Per Executive256.3M
Net Income Per Employee96.9K
Net Income Per Executive72.5M

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.